Efficacy of drug-eluting balloon catheters in the treatment of left main coronary artery bifurcation stenosis: a 12-month follow-up
- 3 December 2025
- journal article
- Published by Media Sphere Publishing Group in Russian Journal of Cardiology and Cardiovascular Surgery
- Vol. 18 (6)
Abstract
Objective. To evaluate the efficacy of drug-eluting balloon catheters (DEBC) in the treatment of left main coronary artery (LMCA) bifurcation lesions. Material and methods. The study included 150 patients who underwent provisional T-stenting of LMCA bifurcations. Patients were randomized into 2 groups. In group 1 (n=75), provisional T-stenting of LMCA was followed by final «kissing» with DEBC in side branch of bifurcation and standard non-compliant balloon catheter in the main branch. In group 2 (n=75), final “kissing” was performed with non-compliant balloon catheter in main and side branches of bifurcation. In addition, patients in both groups were randomized into subgroups according to Medina type of lesion (“true” and “false” bifurcation stenosis). The follow-up period was 12 months. Primary endpoints: cumulative incidence of major adverse cardiac events (MACE) — cardiac death, myocardial infarction, repeated interventions; restenosis at the ostium of the side branch. Treatment results were assessed using stress echocardiography, coronary angiography and intravascular imaging. Results. After 12 months, the total incidence of MACE was higher in group 2 compared to group 1 (6.4% and 2.7%, respectively, p=0.264). The incidence of restenosis at the side branch ostium in patients with «true» and «false» bifurcation stenoses did not differ significantly in within-group comparison (2.9% and 2.4% for group 1; 6.8% and 5.9% for group 2, respectively, p>0.05). However, between-group comparison of these indicators revealed significant differences in patients with «true» stenoses. The incidence of restenosis was 2.9% and 6.8%, respectively (p=0.043). Significant loss of vascular lumen at the mouth of the lateral branch was noted in group 2 among patients with “true” LMCA bifurcations compared to data at the end of surgery. Thus, residual lumen area at the side branch ostium after surgery was 8.2±0.77 mm2, after 12 months — 5.2±0.13 mm2 (p=0.0246). At the same time, there was no significant decrease of residual lumen in patients with «false» LMCA bifurcations in this group (6.9±0.46 and 5.8±0.27 mm2, respectively, p=0.866). In group 1, we found no significant difference when comparing residual lumen area at the mouth of the side branch early after surgery and 12 months later regarding «true» and «false» bifurcations. Conclusion. DEBC in patients with «true» and «false» LMCA bifurcation stenosis has shown equally high efficacy in reducing the incidence of side branch restenosis and target lesion revascularization compared to standard non-compliant balloon catheters. This is confirmed by intravascular imaging and intracoronary physiology data.Keywords
This publication has 20 references indexed in Scilit:
- Percutaneous coronary intervention or coronary artery bypass graft surgery for left main coronary artery disease: A meta-analysis of randomized trialsAmerican Heart Journal, 2020
- Percutaneous vs. surgical revascularization for patients with unprotected left main stenosis: a meta-analysis of 5-year follow-up randomized controlled trialsEuropean Heart Journal - Quality of Care and Clinical Outcomes, 2020
- Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: updated 5-year outcomes from the randomised, non-inferiority NOBLE trialThe Lancet, 2020
- Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery DiseaseNew England Journal of Medicine, 2016
- Paclitaxel-eluting balloon and everolimus-eluting stent for provisional stenting of coronary bifurcations: 12-month results of the multicenter BIOLUX-I studyCardiovascular Revascularization Medicine, 2015
- Six month angiographic result of supplementary paclitaxel-eluting balloon deployment to treat side branch ostium narrowing (SARPEDON)International Journal of Cardiology, 2015
- Long-Term Safety and Efficacy of Stenting Versus Coronary Artery Bypass Grafting for Unprotected Left Main Coronary Artery DiseaseJACC, 2010
- A Meta-Analysis of 3,773 Patients Treated With Percutaneous Coronary Intervention or Surgery for Unprotected Left Main Coronary Artery StenosisJACC: Cardiovascular Interventions, 2009
- Acute and Late Outcomes of Unprotected Left Main Stenting in Comparison With Surgical RevascularizationJACC, 2008
- Single-vessel versus bifurcation stenting for the treatment of distal left main coronary artery disease in the drug-eluting stenting era. Clinical and angiographic insights into the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) and Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registriesAmerican Heart Journal, 2006